![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/475 | |
A61K 31/282 | |||
A61K 31/513 | |||
A61K 31/704 | |||
A61K 31/7048 | |||
A61K 38/28 | |||
A61K 39/395 | |||
A61K 45/00 | |||
A61P 35/00 | |||
A61P 35/04 | |||
C07K 16/28 | |||
C07K 16/32 |
(11) | Number of the document | 2648734 |
(13) | Kind of document | T |
(96) | European patent application number | 11847338.8 |
Date of filing the European patent application | 2011-12-06 | |
(97) | Date of publication of the European application | 2013-10-16 |
(45) | Date of publication and mention of the grant of the patent | 2019-02-13 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2011/002035 |
Date | 2011-12-06 |
(87) | Number | WO 2012/075679 |
Date | 2012-06-14 |
(30) | Number | Date | Country code |
420208 P | 2010-12-06 | US |
(72) |
TSANG, Tom, C, CN
MEADE-TOLLIN, Linda, US
PENNINGTON, Michael, E, US
|
(73) |
Cure Cancer Worldwide LLC,
5050 Avenida de la Colina, Tucson, AZ 85749,
US
|
(54) | METHODS OF METABOLIC TARGETING CANCER CELLS USING CHEMO- AND IMMUNOTHERAPY FOR TREATING CANCER |
METHODS OF METABOLIC TARGETING CANCER CELLS USING CHEMO- AND IMMUNOTHERAPY FOR TREATING CANCER |